Cromatina / Epigenética
Los inhibidores de cromatina/epigenética son compuestos que modulan la estructura y función de la cromatina o interfieren con modificaciones epigenéticas, como la metilación del ADN y la modificación de histonas. Estos inhibidores son herramientas esenciales para estudiar la regulación de la expresión génica y el papel de la epigenética en enfermedades como el cáncer, los trastornos neurológicos y las anomalías del desarrollo. Al dirigirse a los procesos epigenéticos, estos inhibidores pueden alterar los patrones de expresión génica y ofrecer nuevas vías terapéuticas. En CymitQuimica, ofrecemos una amplia selección de inhibidores de cromatina/epigenética de alta calidad para apoyar su investigación en biología molecular, genética y epigenética.
Subcategorías de "Cromatina / Epigenética"
Se han encontrado 2235 productos de "Cromatina / Epigenética"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
PF-9363
CAS:<p>PF-9363 (CTX-3648) is a potent and high selective KAT6A/KAT6B inhibitor. PF-9363 can be used for the research of cancer.</p>Fórmula:C20H20N4O6SPureza:99.03% - 99.7%Forma y color:SolidPeso molecular:444.46UNC1999
CAS:<p>UNC1999 is a orally bioavailable, effective and specific inhibitor of EZH2 (IC50=2 nM) and EZH1 (IC50=45).</p>Fórmula:C33H43N7O2Pureza:99.19% - >99.99%Forma y color:SolidPeso molecular:569.74Deoxyshikonin
CAS:<p>1.</p>Fórmula:C16H16O4Pureza:99.36% - ≥95%Forma y color:SolidPeso molecular:272.31,2-Dipalmitoyl-sn-glycerol
CAS:<p>1,2-Dipalmitoyl-sn-glycerol ((S)-1,2-Dipalmitin) is an analog of the PKC-activating second messenger diacylglycerol (DAG). It weakly activates PKC.</p>Fórmula:C35H68O5Pureza:97.84% - 99.78%Forma y color:SolidPeso molecular:568.91Atractylenolide I
CAS:<p>Atractylenolide-I reduces inflammation, improves sepsis, liver, and kidney function, and enhances EOC cell sensitivity to paclitaxel.</p>Fórmula:C15H18O2Pureza:97.55% - 99.92%Forma y color:SolidPeso molecular:230.38-CHLOROQUINAZOLIN-4(1H)-ONE
CAS:<p>8-CHLOROQUINAZOLIN-4(1H)-ONE is inhibitor of Poly [ADP-ribose] polymerase 1 (human)</p>Fórmula:C8H5ClN2OPureza:98.79%Forma y color:SolidPeso molecular:180.59ICG001
CAS:<p>ICG001 antagonizes Wnt signaling, binds CBP with 3 μM IC50, not p300.</p>Fórmula:C33H32N4O4Pureza:99.06% - 99.95%Forma y color:SolidPeso molecular:548.63(R)-(-)-JQ1 Enantiomer
CAS:<p>(R)-(-)-JQ1 Enantiomer is the stereoisomer of (+)-JQ1. (+)-JQ1 is a BET bromodomain inhibitor, acting on BRD4(1/2)(IC50 of 77 nM/33 nM in a cell-free assay)</p>Fórmula:C23H25ClN4O2SPureza:99.38%Forma y color:SolidPeso molecular:456.99MI-463
CAS:<p>MI-463 is a potent and orally bioavailable inhibitor of the menin-mLL interaction (IC50: 15.3 nM).</p>Fórmula:C24H23F3N6SPureza:99.18% - >99.99%Forma y color:SolidPeso molecular:484.54Fucosterol
CAS:<p>Fucosterol, from E. stolonifera, has anti-diabetic, anti-adipogenic, anti-cancer properties; it affects PPARα and C/EBPα to control fat cell formation.</p>Fórmula:C29H48OPureza:98.39% - 99.68%Forma y color:White PowderPeso molecular:412.69KC7F2
CAS:<p>KC7F2 is a potent HIF-1 pathway inhibitor with potential anti-cancer activity.</p>Fórmula:C16H16Cl4N2O4S4Pureza:98% - 99.11%Forma y color:SolidPeso molecular:570.38JQEZ5
CAS:<p>JQEZ5 is an inhibitor of EZH2 lysine methyltransferase (IC50 = 11.1 nM).</p>Fórmula:C30H38N8O2Pureza:98.14% - ≥98%Forma y color:SolidPeso molecular:542.68SGC707
CAS:<p>SGC707 is a potent, selective, and cell-active allosteric inhibitor of PRMT3.</p>Fórmula:C16H18N4O2Pureza:98.45% - 99.79%Forma y color:SolidPeso molecular:298.34BI-7273
CAS:<p>BI-7273 is an effective, specific, BRD9 BD Inhibitor, which can infiltrate cell.</p>Fórmula:C20H23N3O3Pureza:97.37% - 99.57%Forma y color:SolidPeso molecular:353.41Rucaparib hydrochloride
CAS:<p>Rucaparib hydrochloride (AG014699) is an oral PARP inhibitor with Ki 1.4 nM for PARP1 and hinders H6PD, studied in CRPC research.</p>Fórmula:C19H19ClFN3OForma y color:SolidPeso molecular:359.83XMD8-92
CAS:<p>XMD8-92 is an effective and specific BMK1/ERK5 inhibitor (Kd: 80 nM).</p>Fórmula:C26H30N6O3Pureza:98.21%Forma y color:SolidPeso molecular:474.55Rucaparib acetate
CAS:<p>Rucaparib acetate, an oral PARP-1, -2, -3 inhibitor (Ki 1.4 nM for PARP1), also moderately inhibits H6PD; promising for CRPC research.</p>Fórmula:C21H22FN3O3Forma y color:SolidPeso molecular:383.423GSK-LSD1 dihydrochloride
CAS:<p>GSK-LSD1 dihydrochloride: potent LSD1 inhibitor, >1000x selective over MAO-A/B, LSD2, IC50: 16 nM.</p>Fórmula:C14H22Cl2N2Pureza:98.72% - >99.99%Forma y color:SolidPeso molecular:289.24NVP-TNKS656
CAS:<p>NVP-TNKS656 (TNKS656) is a highly potent, selective, and orally active TNKS2 inhibitor.</p>Fórmula:C27H34N4O5Pureza:99.59%Forma y color:SolidPeso molecular:494.58Menin-MLL inhibitor 20
CAS:<p>Menin-MLL inhibitor 20 is an irreversible inhibitor of menin-MLL interaction with antitumor activities.</p>Fórmula:C33H40N8O4Pureza:97.77%Forma y color:SolidPeso molecular:612.72TCS PIM-1 1
CAS:<p>TCS PIM-1 1 (SC 204330) is a potent ATP-competitive inhibitor of Pim-1 kinase with an IC50 of 50 nM, selective over MEK1/2 and Pim-2.</p>Fórmula:C18H11BrN2O2Pureza:97% - 97.98%Forma y color:SolidPeso molecular:367.2MI-538
CAS:<p>MI-538 is an interaction between menin and MLL fusion proteins inhibitor(IC50 of 21 nM).</p>Fórmula:C27H25F3N8OSPureza:99.61% - 99.8%Forma y color:SolidPeso molecular:566.6RBN012759
CAS:<p>RBN012759 inhibits PARP14 protein and is more than 300-fold selective over all PARP family members.Cost-effective and quality-assured.</p>Fórmula:C19H23FN2O3SPureza:98.87% - 99.96%Forma y color:SolidPeso molecular:378.46GLPG0634 analog
CAS:<p>GLPG0634 analog (GLPG0634 analogue) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for JAK1/2/3 and TYK2, respectively.</p>Fórmula:C23H18N6O2Pureza:99.52% - >99.99%Forma y color:SolidPeso molecular:410.43Ethyl 3,4-dihydroxybenzoate
CAS:<p>Ethyl 3,4-dihydroxybenzoate (EDHB): a prolyl hydroxylase inhibitor attenuates acute hypobaric hypoxia mediated vascular leakage in brain.</p>Fórmula:C9H10O4Pureza:99.88%Forma y color:White Crystal Or PowderPeso molecular:182.17Ruboxistaurin
CAS:<p>Ruboxistaurin (LY333531) is a selective PKC beta inhibitor, Ki 2 nM, inhibits beta I/II (IC50: 4.7/5.9 nM), orally active.</p>Fórmula:C28H28N4O3Forma y color:SolidPeso molecular:468.55DMOG
CAS:<p>DMOG (Dimethyloxalylglycine), an antagonist of the α-ketoglutarate cofactor, is an inhibitor for HIF prolyl hydroxylase.</p>Fórmula:C6H9NO5Pureza:80.23% - 99.98%Forma y color:SolidPeso molecular:175.14EB-47 dihydrochloride
CAS:<p>EB 47 is an effective inhibitor of PARP-1 (IC50: 45 nM).</p>Fórmula:C24H29Cl2N9O6Forma y color:SolidPeso molecular:610.45SC-43
CAS:<p>SC-43 is a potent and orally active agonist of SHP-1 (PTPN6).</p>Fórmula:C21H13ClF3N3O2Pureza:98.44%Forma y color:SolidPeso molecular:431.8Ritlecitinib tosylate
CAS:<p>Ritlecitinib (PF-06651600) is a potent, selective JAK3 inhibitor with proven in vivo efficacy, low clearance, and has undergone clinical trials.</p>Fórmula:C22H27N5O4SForma y color:SolidPeso molecular:457.549Amodiaquine
CAS:<p>Amodiaquine is a synthetic aminoquinoline, used to treat malaria.</p>Fórmula:C20H22ClN3OPureza:99.78% - 99.99%Forma y color:Crystals From Absolute Ethanol SolidPeso molecular:355.86MR837
CAS:<p>MR837 (NSD2-PWWP1 antagonist 3f) is a NSD2-PWWP1 antagonist.</p>Fórmula:C16H14N2OSPureza:99.77% - 99.85%Forma y color:SolidPeso molecular:282.36Pinometostat
CAS:<p>Pinometostat (EPZ-5676) is a potent DOT1L histone methyltransferase inhibitor. Pinometostat has antitumor activity. Cost effective and quality assured.</p>Fórmula:C30H42N8O3Pureza:99.19% - 99.86%Forma y color:SolidPeso molecular:562.71MS31 trihydrochloride
<p>MS31 trihydrochloride: a selective SPIN1 inhibitor, binds H3K4me3 (IC50: 77-243 nM), non-toxic to healthy cells.</p>Fórmula:C20H30Cl3N3O2Forma y color:SolidPeso molecular:450.83Anacardic Acid
CAS:<p>Anacardic Acid (6-pentadecylsalicylic Acid) is an effective inhibitor of p300 and p300/CBP-associated factor histone acetyltranferases.</p>Fórmula:C22H36O3Pureza:97.47% - 99.87%Forma y color:SolidPeso molecular:348.525,7,4'-Trimethoxyflavone
CAS:<p>5,7,4'-Trimethoxyflavone (4',5,7-Trimethoxyflavone) is isolated from Kaempferia parviflora (KP) which is a medicinal plant from Thailand.</p>Fórmula:C18H16O5Pureza:97.53%Forma y color:SolidPeso molecular:312.32PF-CBP1 hydrochloride
CAS:<p>PF-CBP1 HCl selectively inhibits CREBBP bromodomain (IC50: 125 nM) and p300 (IC50: 363 nM).</p>Fórmula:C29H37ClN4O3Pureza:97.11% - 99.02%Forma y color:SolidPeso molecular:525.08MK-8617
CAS:<p>MK-8617 is an orally available HIF PHD1 3 pan-inhibitor, inhibiting PHD1/2/3 (IC50: 1.0/1.0/14 nM).</p>Fórmula:C24H21N5O4Pureza:99.38% - >99.99%Forma y color:SolidPeso molecular:443.45Abrocitinib
CAS:<p>Abrocitinib (PF-04965842) (PF-04965842) is a potent, specific and orally-active JAK1 inhibitor (IC50s: 29/803 nM for JAK1/2).</p>Fórmula:C14H21N5O2SPureza:99.09% - 99.91%Forma y color:SolidPeso molecular:323.41C-7280948
CAS:<p>C-7280948 is a PRMT1 inhibitor.</p>Fórmula:C14H16N2O2SPureza:99.55% - ≥95%Forma y color:SolidPeso molecular:276.35Daphnetin
CAS:<p>Daphnetin (7,8-Dihydroxycoumarin), a natural coumarin derivative, is a protein kinase inhibitor with inhibitory for EGFR (IC50: 7.67 μM), PKA (IC50: 9.33 μM),</p>Fórmula:C9H6O4Pureza:97.47% - 99.8%Forma y color:SolidPeso molecular:178.14B2
CAS:<p>B2 (Linazolamide intermediate B impurity 2) promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease</p>Fórmula:C20H17ClN4O3Pureza:99.66%Forma y color:SolidPeso molecular:396.83XAV-939
CAS:<p>XAV-939 (NVP-XAV939) shows the selective inhibition against Wnt/β-catenin-mediated transcription by tankyrase1/2 inhibition (IC50: 11/4 nM in cell-free assay).</p>Fórmula:C14H11F3N2OSPureza:97.47% - 99.67%Forma y color:SolidPeso molecular:312.31AZD1208
CAS:<p>AZD1208 is a novel, orally bioavailable, highly selective PIM kinase inhibitor with single nanomolar potency against all three PIM kinases.</p>Fórmula:C21H21N3O2SPureza:97.24% - 99.83%Forma y color:SolidPeso molecular:379.48dBET6
CAS:<p>dBET6 is a selective and cell-permeable degrader of BET based on PROTAC (IC50: 14 nM). It has antitumor activity.</p>Fórmula:C42H45ClN8O7SPureza:97.57% - 99.12%Forma y color:SolidPeso molecular:841.37Niraparib hydrochloride
CAS:<p>Niraparib hydrochloride (MK-4827) is a PARP inhibitor with potential cancer treatment effects, causing DNA damage and apoptosis.</p>Fórmula:C19H21ClN4OPureza:99.26%Forma y color:SolidPeso molecular:356.85Birabresib
CAS:<p>Birabresib (MK-8628) is a synthetic, small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins 2, 3 and 4</p>Fórmula:C25H22ClN5O2SPureza:98.3% - 99.36%Forma y color:SolidPeso molecular:491.99Rucaparib Phosphate
CAS:<p>Rucaparib Phosphate (PF-01367338 phosphate) is an inhibitor of PARP that is used in clinical therapy to sensitize cancer cells to chemotherapy.</p>Fórmula:C19H18FN3O·H3PO4Pureza:99.37%Forma y color:SolidPeso molecular:421.363-methyl-1,2,3,4-tetrahydroquinazolin-2-one
CAS:<p>3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .</p>Fórmula:C9H10N2OPureza:99.3% - 99.64%Forma y color:SolidPeso molecular:162.19SHR0302
CAS:<p>SHR0302 (ARQ252) is a JAK inhibitor that binds JAK1 with stronger affinity than others (Selectivity for JAK1 is more than 10 times for JAK2, 77 times for JAK3,</p>Fórmula:C18H22N8O2SPureza:99.11%Forma y color:SolidPeso molecular:414.48MI-503
CAS:<p>MI-503 is an efficient and selective Menin-MLL inhibitor. MI-503 has a significant inhibitory effect on human MLL leukemia cell line. Cost-effective and quality-assured.</p>Fórmula:C28H27F3N8SPureza:99.87% - 99.99%Forma y color:SolidPeso molecular:564.63Tubacin
CAS:<p>Tubacin is a highly potent and selective, reversible, cell-permeable HDAC6 inhibitor with an IC50 of 4 nM, approximately 350-fold selectivity over HDAC1.</p>Fórmula:C41H43N3O7SPureza:97.62% - 98.75%Forma y color:SolidPeso molecular:721.86SETDB1-TTD-IN-1 TFA
<p>SETDB1-TTD-IN-1 TFA: potent, selective SETDB1-TTD inhibitor (Kd: 88 nM), useful for related biological research.</p>Fórmula:C30H32F3N5O4Forma y color:SolidPeso molecular:583.6BYK204165
CAS:<p>BYK204165 (RT-017290) is a potent PARP inhibitor (PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay)</p>Fórmula:C15H12N2O2Pureza:99.61%Forma y color:SolidPeso molecular:252.27J-147
CAS:<p>J-147, a curcumin derivative, is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging.</p>Fórmula:C18H17F3N2O2Pureza:99.61% - >99.99%Forma y color:SolidPeso molecular:350.33Alobresib
CAS:<p>Alobresib (Vorolanib) is an inhibitor of BET bromodomain,is an antineoplastic drug candidate.</p>Fórmula:C26H23N5O2Pureza:97.63%Forma y color:SolidPeso molecular:437.495-AIQ
CAS:<p>5-aminoisoquinolin-1(2H)-one is the inhibitor of calf thymus PARP1.</p>Fórmula:C9H8N2OPureza:95.95%Forma y color:SolidPeso molecular:160.17BAZ1A-IN-1
CAS:<p>BAZ1A-IN-1, a potent inhibitor, KD 0.52 μM against BAZ1A, is effective in high-BAZ1A cancer cells, not in low-BAZ1A ones.</p>Fórmula:C16H12N4O3SPureza:99.87%Forma y color:SolidPeso molecular:340.36Ruxolitinib (S enantiomer)
CAS:<p>Ruxolitinib S enantiomer (INCB18424) is the S-enantiomer of Ruxolitinib. Ruxolitinib is the first potent, selective JAK1/2 inhibitor.</p>Fórmula:C17H18N6Pureza:99.37% - 99.79%Forma y color:SolidPeso molecular:306.36ML367
CAS:<p>ML367 inhibits ATAD5 stabilization with low micromolar activity, serving as a probe molecule.</p>Fórmula:C19H12F2N4Pureza:99.39%Forma y color:SolidPeso molecular:334.32I-CBP112
CAS:<p>I-CBP112 is a specific and potent acetyl-lysine competitive protein-protein interaction inhibitor targeting the CBP/p300 bromodomains.</p>Fórmula:C27H36N2O5Pureza:98.18%Forma y color:SolidPeso molecular:468.59CPI-455
CAS:<p>CPI-455 is a specific KDM5 inhibitor.</p>Fórmula:C16H14N4OPureza:97.87% - 99.03%Forma y color:SolidPeso molecular:278.31Momelotinib HCl
CAS:<p>Momelotinib HCl is a JAK1/2 inhibitor, reducing anemia in myelofibrosis (MF) patients.</p>Fórmula:C23H24Cl2N6O2Forma y color:SolidPeso molecular:487.38BCI-121
CAS:<p>BCI-121 is a substrate-competitive SMYD3 inhibitor that inhibits the proliferation of the cancer cell.</p>Fórmula:C14H18BrN3O2Pureza:99.67%Forma y color:SolidPeso molecular:340.22SGC2085 HCl
CAS:<p>SGC2085: potent, selective CARM1 inhibitor; IC50=50 nM; >100x selectivity vs other PRMTs; impacts cancer growth.</p>Fórmula:C19H24N2O2·HClPureza:99.91%Forma y color:SolidPeso molecular:348.87Splitomicin
CAS:<p>Splitomicin (1-Naphthalenepropanoic Acid) (IC50 of 60 μM), a specific inhibitor of NAD(+)-dependent histone deacetylase Sir2p, displays a high activity in a</p>Fórmula:C13H10O2Pureza:97.09% - 99.11%Forma y color:SolidPeso molecular:198.224-Phenylbutyric acid
CAS:<p>4-Phenylbutyric acid (Benzenebutyric acid) is a HDAC inhibitor and an endoplasmic reticulum stress (ERS) inhibitor. Cost-effective and quality-assured.</p>Fórmula:C10H12O2Pureza:98.40% - 99.76%Forma y color:SolidPeso molecular:164.2Gandotinib
CAS:<p>LY2784544(Gandotinib (LY2784544)) is a potent JAK2 inhibitor (IC50: 3 nM), effective in JAK2V617F(Ki: 0.245 nM).</p>Fórmula:C23H25ClFN7OPureza:99.33% - 99.86%Forma y color:SolidPeso molecular:469.94Protein kinase inhibitor 6
CAS:<p>Protein kinase inhibitor 6 is a protein kinase inhibitor.</p>Fórmula:C13H9FN2SPureza:98.01%Forma y color:SolidPeso molecular:244.29Iso-H7 dihydrochloride
CAS:<p>Iso-H7 dihydrochloride is a less potent inhibitor of phosphokinase C than H-7.</p>Fórmula:C14H19Cl2N3O2SPureza:99.53%Forma y color:White Crystalline SolidPeso molecular:364.29dencichine
CAS:<p>Dencichine (ODAP) is a neurotoxic agent and a haemostatic agent, which relates to modulation of the coagulation system, and fibrinolytic system.</p>Fórmula:C5H8N2O5Pureza:99.93% - ≥95%Forma y color:SolidPeso molecular:176.13Cerdulatinib
CAS:<p>Cerdulatinib (PRT2070) is an novel oral dual Syk/JAK inhibitor.</p>Fórmula:C20H27N7O3SPureza:98.74% - 99.49%Forma y color:SolidPeso molecular:445.543-TYP
CAS:<p>3-TYP (3-(1H-1,2,3-triazol-4-yl) pyridine) is a selective SIRT3 inhibitor.</p>Fórmula:C7H6N4Pureza:99.16% - >99.99%Forma y color:SolidPeso molecular:146.15Nudifloramide
CAS:<p>Nudifloramide (1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide) is one of the end degradation products of nicotinamide-adenine dinucleotide (NAD).</p>Fórmula:C7H8N2O2Pureza:99.7% - ≥95%Forma y color:SolidPeso molecular:152.15M1001
CAS:<p>M1001 is a HIF-2α agonist.</p>Fórmula:C17H17N3O2SPureza:98.83%Forma y color:SolidPeso molecular:327.4Mivebresib
CAS:<p>Mivebresib (ABBV-075) is a potent BET inhibitor with antitumor effects, disrupting gene expression and MYC, TMPRSS2-ETS proteins.</p>Fórmula:C22H19F2N3O4SPureza:98.74% - 99.32%Forma y color:SolidPeso molecular:459.47GSK467
CAS:<p>GSK467 is a potent and selective inhibitor of KDM5 (JARID1)(Ki : 10 nM).</p>Fórmula:C17H13N5O2Pureza:99.55%Forma y color:SolidPeso molecular:319.32MG 149
CAS:<p>MG 149 (Tip60 HAT inhibitor) is a selective and potent Tip60 inhibitor with IC50 of 74 uM, similar potentcy for MOF(IC50= 47 uM).</p>Fórmula:C22H28O3Pureza:98.69% - 99.86%Forma y color:SolidPeso molecular:340.46Amifostine trihydrate
CAS:<p>Amifostine trihydrate (WR2721) is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin.</p>Fórmula:C5H15N2O3PS·3H2OPureza:99.71% - 99.80%Forma y color:SolidPeso molecular:268.27Tofacitinib Citrate
CAS:<p>Tofacitinib Citrate (CP-690550 citrate) is a a potent, cell-permeable inhibitor of JAK1/2/3 (IC50s: 1/20/112 nM).</p>Fórmula:C22H28N6O8Pureza:99.19% - 99.75%Forma y color:SolidPeso molecular:504.49DDP-38003 trihydrochloride
<p>DDP-38003 trihydrochloride is a novel, orally available histone lysine-specific demethylase 1A (KDM1A/LSD1) inhibitor with an IC50 of 84 nM.</p>Fórmula:C21H29Cl3N4OPureza:98%Forma y color:SolidPeso molecular:459.84WHI-P154
CAS:<p>WHI-P154 (Jak3 inhibitor ii) is a potent JAK3 inhibitor.</p>Fórmula:C16H14BrN3O3Pureza:98% - 99.67%Forma y color:SolidPeso molecular:376.2Selisistat
CAS:<p>Selisistat (EX-527) is a potent and specific inhibitor of the deacetylase SIRT1 (IC50=38 nM).</p>Fórmula:C13H13ClN2OPureza:98.53% - 99.94%Forma y color:SolidPeso molecular:248.71Fedratinib
CAS:<p>Fedratinib (TG-101348) (TG101348) is an ATP-competitive inhibitor of JAK2 (IC50: 3 nM) with significantly less potent activity against JAK3.</p>Fórmula:C27H36N6O3SPureza:97.31% - 99.96%Forma y color:SolidPeso molecular:524.68BI 2536
CAS:<p>BI2536 is an effective Plk1 inhibitor (IC50: 0.83 nM). It has 4- and 11-fold greater selectivity than Plk2 and Plk3.</p>Fórmula:C28H39N7O3Pureza:98% - 99.88%Forma y color:SolidPeso molecular:521.65(+)-JQ-1
CAS:<p>(+)-JQ-1 (JQ1) is a BET bromine domain inhibitor that inhibits BRD4 (1/2) (IC50=77/33 nM) with specificity and reversibility.</p>Fórmula:C23H25ClN4O2SPureza:97.57% - ≥95%Forma y color:SolidPeso molecular:456.99Niraparib tosylate
CAS:<p>Niraparib tosylate (MK-4827 (tosylate))(with IC50 of 3.8 nM/2.1 nM) is a selective PARP1/PARP2 inhibitor.</p>Fórmula:C19H20N4O·C7H8O3SPureza:99.34% - 99.87%Forma y color:SolidPeso molecular:492.59AZD-2461
CAS:<p>AZD2461 is a novel PARP inhibitor.</p>Fórmula:C22H22FN3O3Pureza:98% - 99.87%Forma y color:SolidPeso molecular:395.43Acetyl Pentapeptide-1 acetate
<p>Acetyl Pentapeptide-1 acetate is an histone deacetylase inhibitor.</p>Fórmula:C34H55N9O12Pureza:99.09%Forma y color:SolidPeso molecular:781.86Bobcat339
CAS:<p>Bobcat339 is a novel cytosine-based TET enzyme inhibitor (IC50s: 33/73 uM for TET1/2), but not DNMT3a, does not inhibit the DNA methyltransferase DNMT3a.</p>Fórmula:C16H12ClN3OPureza:97.79% - 99.24%Forma y color:SolidPeso molecular:297.74Methyl L-histidinate dihydrochloride
CAS:<p>The inhibitory effect of Methyl L-histidinate dihydrochloride (L-Histidine methyl ester dihydrochloride) on histidine decarboxylase in Sprague-Dawley rat</p>Fórmula:C7H13Cl2N3O2Pureza:99.74%Forma y color:White To Off-White PowderPeso molecular:242.1A-196
CAS:<p>A-196 is a potent and selective inhibitor of SUV420 h1 and SUV420 h2 with IC50 values of 0.025 and 0.144 μM, respectively; more than 100-fold selective over</p>Fórmula:C18H16Cl2N4Pureza:99.92%Forma y color:SolidPeso molecular:359.25PFI-1
CAS:<p>PFI-1 (PF-6405761), a specific BET (bromodomain-containing protein) inhibitor for BRD4, is with the IC50 of 0.22 μM in a cell-free assay.</p>Fórmula:C16H17N3O4SPureza:98.74% - 99.19%Forma y color:SolidPeso molecular:347.39Isoxazole
CAS:<p>Isoxazole (1,2-oxazole) is the inhibitor of acetylcholinesterase (AChE). The ligands of Isoxazole bind to and inhibit the Sxc- antiporter.</p>Fórmula:C3H3NOPureza:99.34%Forma y color:Colorless LiquidPeso molecular:69.06Baricitinib phosphate
CAS:<p>Baricitinib phosphate (INCB028050) is a selective orally bioavailable JAK1/JAK2 inhibitor.</p>Fórmula:C16H20N7O6PSPureza:99.4% - 99.82%Forma y color:SolidPeso molecular:469.41Aurora kinase inhibitor-2
CAS:<p>Aurora kinase inhibitor-2 (IUN-70219) is a cell-permeable anilinoquinazoline that inhibit the activity of Aurora A (IC50 = 0.39 M).</p>Fórmula:C23H20N4O3Pureza:98.66%Forma y color:SolidPeso molecular:400.435-Ph-IAA
CAS:<p>5-Ph-IAA is a derivative of Indole-3-acetic acid (IAA), which is a plant hormone and acts as an enzyme or prodrug combination for cancer gene therapy.</p>Fórmula:C16H13NO2Pureza:99.37% - 99.973%Forma y color:SolidPeso molecular:251.28WHI-P97 HCl
<p>WHI-P97 HCl is a potent and selective JAK-3 inhibitor.</p>Fórmula:C16H14Br2ClN3O3Pureza:99.49%Forma y color:SolidPeso molecular:491.56Hesperadin
CAS:<p>Hesperadin(IC50=250 nM) effectively inhibits Aurora B.</p>Fórmula:C29H32N4O3SPureza:98.04% - 99.44%Forma y color:SolidPeso molecular:516.652-hexyl-4-Pentynoic Acid
CAS:<p>2-hexyl-4-Pentynoic Acid, a valproic acid (VPA) derivatives, is a potent and robust HDACs inhibitor with IC50 value of 13 μM.</p>Fórmula:C11H18O2Pureza:98%Forma y color:SolidPeso molecular:182.26
